Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

Lifespan Studies and Pipeline Size

Joan says Tornado holds about 80 rapalog analogs and plans targeted preclinical lifespan testing for selected compounds.

Play episode from 01:10:28
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app